celecoxib has been researched along with Basal Cell Nevus Syndrome in 1 studies
Basal Cell Nevus Syndrome: Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We then assessed the effects of celecoxib on the development of BCCs in a 3-year, double-blinded, randomized clinical trial in 60 (PTCH1(+/-)) patients with the basal cell nevus syndrome." | 5.14 | Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. ( Aszterbaum, M; Athar, M; Barsanti, F; Bickers, DR; Cappola, C; Epstein, EH; Estevez, N; Hebert, J; Hwang, J; Khaimskiy, Y; Kim, A; Kohn, MA; Kopelovich, L; Lu, Y; McCulloch, CE; So, PL; Tang, JY; Tang, X, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, JY | 1 |
| Aszterbaum, M | 1 |
| Athar, M | 1 |
| Barsanti, F | 1 |
| Cappola, C | 1 |
| Estevez, N | 1 |
| Hebert, J | 1 |
| Hwang, J | 1 |
| Khaimskiy, Y | 1 |
| Kim, A | 1 |
| Lu, Y | 1 |
| So, PL | 1 |
| Tang, X | 1 |
| Kohn, MA | 1 |
| McCulloch, CE | 1 |
| Kopelovich, L | 1 |
| Bickers, DR | 1 |
| Epstein, EH | 1 |
1 trial available for celecoxib and Basal Cell Nevus Syndrome
| Article | Year |
|---|---|
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; | 2010 |